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Summary
 
The germinal center (GC) is an anatomic compartment found in peripheral lymphoid organs,
wherein B cells undergo clonal expansion, somatic mutation, switch recombination, and reac-
tivate immunoglobulin gene V(D)J recombination. As a result of somatic mutation, some GC
B cells develop higher affinity antibodies, whereas others suffer mutations that decrease affinity,
and still others may become self-reactive. It has been proposed that secondary V(D)J rearrange-
ments in GCs might rescue B cells whose receptors are damaged by somatic mutations. Here
we present evidence that mature human tonsil B cells coexpress conventional light chains and
recombination associated genes, and that they extinguish recombination activating gene and
terminal deoxynucleotidyl transferase expression when their receptors are cross-linked. Thus,
the response of the recombinase to receptor engagement in peripheral B cells is the opposite of
the response in developing B cells to the same stimulus. These observations suggest that recep-
tor revision is a mechanism for receptor diversification that is turned off when antigen receptors
are cross-linked by the cognate antigen.
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B
 
lymphocytes develop clonally restricted antigen spe-
cific receptors by randomly joining Ig variable (V), di-
versity (D), and joining (J) gene segments by V(D)J recom-
bination (1). V(D)J recombination is a highly regulated
process that requires coordinate expression of a series of
lymphoid-specific and non-lymphoid-specific genes (2).
Among the lymphoid-restricted components, only recom-
bination activating genes 
 
RAG1
 
1
 
 and 
 
RAG2
 
 are essential for
V(D)J recombination (3–6). Together, these two proteins
form a complex that initiates Ig genes rearrangements by
recognizing the recombination signal sequences (RSSs) and
cleaving DNA (7-13). There are three distinct waves of
RAG expression in the bone marrow (14, 15). These
waves of RAG expression correspond to heavy and light
chain gene rearrangements and receptor editing (16–18).
In addition to RAG1 and RAG2, B cell progenitors also
express a series of other proteins that are developmentally
restricted, B cell specific, and required for efficient anti-
body gene assembly (19, 20). These include the terminal
deoxynucleotidyl transferase (TdT) and murine 
 
l
 
5 or hu-
man 
 
l
 
-like, and V-preB proteins. TdT increases antibody
diversity by adding nontemplated nucleotides to V(D)J
junctions (21, 22) whereas 
 
l
 
5 and V-preB associate with
each other to form the surrogate light chain (
 
C
 
L) (23–26).
The 
 
C
 
L is believed to enhance the efficiency of B cell de-
velopment by pairing with heavy chains before a conven-
tional light chain is assembled. In the absence of 
 
l
 
5, B cell
development is severely impaired at the pro-B cell to pre-B
 
1
 
Abbreviations used in this paper:
 
 GC, germinal center; FM, follicular man-
tle; 
 
C
 
L, surrogate light chain; LM, ligation-mediated; RAG, recombina-
tion activating gene; RSS, recombination signal sequences; RT, reverse
transcriptase; TdT, terminal deoxynucleotidyl transferase.
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cell transition because pro-B cells that express a heavy chain
in the absence of a light chain are unable to develop into
pre-B cells (23–26). Expression of all of these genes is
thought to be terminated before mature B cells exit the bone
marrow, ensuring that each B cell produces a single fixed
antigen receptor that can be clonally selected and expanded
in the periphery in response to specific antigen (19, 20).
Clonal expansion of specific antigen receptor–bearing B
cells occurs in the germinal center (GC) (27–29). During
the GC reaction, B cells with low affinity antigen receptors
can improve the affinity of their receptors by somatic hy-
permutation (30–32). In addition, mouse GC B cells have
been shown to be able to reactivate V(D)J recombination
(33–37). The finding that V(D)J recombination occurs in
mature B cells was unexpected because V gene rearrange-
ments alter antibody specificity, and clonal selection implies
that cells expanded in the GC retain their specificity. How-
ever, if appropriately regulated, new recombination might
function to rescue B cells that make deleterious somatic
mutations, or serve as an alternative mechanism to somatic
mutation for producing cells with high affinity antibodies.
Here, we report experiments that show V(D)J rearrange-
ment in mature peripheral B cells in humans and that sug-
gest that recombination in these cells is regulated by anti-
gen receptor cross-linking.
 
Materials and Methods
 
Human Cell Isolation and Fractionation.
 
Tonsil B cells and B
cell subsets were prepared as previously described (38). In brief,
after depletion of non-B cells, tonsil mononuclear cells were
stained with biotin-labeled goat anti–human IgD (Amersham
Pharmacia Biotech, Piscataway, NJ), which was visualized with
streptavidin-FITC (Immunotech, Westbrook, ME), and PE-labeled
mouse anti–human CD38 (Becton Dickinson, San Jose, CA). Cells
were then sorted into the following fractions: (
 
a
 
) IgD
 
1
 
CD38
 
2
 
follicular mantle (FM) B cells; (
 
b
 
) IgD
 
2
 
CD38
 
1
 
 GC B cells; and (
 
c
 
)
IgD
 
2
 
CD38
 
2
 
 memory B cells. Alternatively, tonsil mononuclear
cells were stained with PE-labeled mouse anti–human CD38
(Becton Dickinson) and rat anti–human CD77 (Immunotech)
that was visualized with FITC-labeled sheep anti–rat IgM (Sero-
tec, Ltd., Kidlington, UK) and sorted into three fractions: (
 
a
 
)
CD38
 
1
 
CD77
 
1
 
 centroblasts; (
 
b
 
) CD38
 
1
 
CD77
 
2
 
 centrocytes; and
(
 
c
 
) a CD38
 
2
 
CD77
 
2
 
 fraction that contained both naive FM B cells
and memory B cells. To analyze for V-preB expression, tonsil
cells were stained with tricolor anti-CD38 (Caltag Labs., San
Francisco, CA), PE-labeled IgG1 monoclonal anti–V-preB anti-
body (4G7) (Schiff, C., manuscript in preparation), and FITC la-
beled anti-IgM (DAKO Corp., Carpinteria, CA), or anti-
 
k
 
(DAKO Corp.) and/or anti-
 
l
 
 (Ortho Diagnostic Systems, Rari-
tan, NJ) mAb.
 
Cell Culture.
 
Human FM and GC B cells were maintained in
tissue culture as previously reported
 
 
 
(38). In brief, 5
 
 3 
 
10
 
5
 
 cells
were cocultured during 3 d with CD40L-transfected L cells and
stimulated with: IL-2 (10 U/ml), or IL-4 (50 U/ml), or IL-10
(100 ng/ml) or anti-
 
k
 
, or anti-
 
l
 
, or both, or Fab
 
9
 
2 anti-
 
k
 
 
 
1
 
 anti-
 
l
 
,
or irrelevant control IgG, at the indicated concentrations in mi-
crograms per milliliter (Kallestad Lab., Inc., Austin, TX).
 
Linker-ligation PCR.
 
DNA was extracted from 2 
 
3 
 
10
 
6
 
 cells
in agarose plugs (35) and ligated to the BW linker at 20 pM as
previously described (39). PCR was performed using AmpliTaq
Gold Taq polymerase (PE Applied Biosystems, Foster City, CA).
In the first round of PCR we used linker primer BW-1 or
BW-1H (39) and either J
 
H
 
6-1 or J
 
k
 
5-1 (J
 
H
 
6-1, 5
 
9
 
GCTGGTCT-
GGGGTGACCTCTCTCCGCTTC3
 
9
 
; J
 
k
 
5-1, 5
 
9
 
CAAACGTA-
AGTGCACTTTCCTAATGC3
 
9
 
). Samples were amplified for
15 cycles of 40 s at 94
 
8
 
C, 40 s at 66
 
8
 
C, and 1 min at 72
 
8
 
C, fol-
lowed by a final 10-min extension step at 72
 
8
 
C. 1 
 
m
 
l was then used
for an additional 40 cycles of PCR containing a second nested lo-
cus-specific primer (J
 
H
 
6-2, 5
 
9
 
GTGGTGGGACTCTGTCCG-
CTCCAAGGC3
 
9
 
; J
 
k
 
5-2, 5
 
9
 
GTTTGAGATATTAGCTCAGG-
TCAATTC3
 
9
 
) and either BW-1 or the closely related BW-1H
linker primers (39). The expected size for the specific J
 
H
 
6 or J
 
k
 
5
RSS signal break products are 322 and 249 bp, respectively. Con-
trol PCR assays used the J
 
k
 
5-R primer specific for the human J
 
k
 
5
coding exon (J
 
k
 
5-R, 5
 
9
 
GTTTAATCTCCAGTCGTGTCCC-
TTG3
 
9
 
) combined with J
 
k
 
5-2 to amplify a germline 260-bp in-
ternal Ig 
 
k 
 
locus fragment from the same linker-ligated DNA
samples. PCR products were analyzed on 2% agarose gels and hy-
bridized with either J
 
H
 
6 or J
 
k
 
5 internal probes (J
 
H
 
6, 5
 
9
 
GCT-
TGCGGTTGGACTTCCCAGCCGACAGTGGTGGTCTG-
GCTTCTGA3
 
9
 
; J
 
k
 
5, 5
 
9
 
GAACAGCCAAGCGCTAGCCAGT-
TAAGTGAGGCATCTCAATTGCAAG3
 
9
 
).
 
Cloning and Sequencing.
 
PCR products were gel purified with
the Qiaquick kit (QIAGEN Inc., Chatsworth, CA) and cloned
using the TA cloning system (Invitrogen Corp., Carlsbad, CA).
Double-stranded DNA sequences were obtained using T7 and
M13 primers with a Dye Terminator Cycle Sequencing kit (PE
Applied Biosystems). The sequencing reactions were run and an-
alyzed on a genetic analyzer (model 310; PE Applied Biosystems).
 
RNA Preparation and Reverse Transcriptase PCR.
 
Total RNA
was extracted from 2 
 
3 
 
10
 
5
 
 cells using TRIzol Reagent (GIBCO
BRL, Gaithersburg, MD) and reverse transcribed in 20 
 
m
 
l with
Superscript II (GIBCO BRL). For reverse transcriptase (RT)-PCR
reactions, 2 
 
m
 
l of cDNA were amplified for 26, 28, or 30 (Ig
 
b
 
,
 
l
 
-like, and V-preB) or 36, 38, or 40 (RAG1, RAG2, and TdT)
cycles of 30 s at 94
 
8
 
C, 30 s at 60
 
8
 
C and 30 s at 72
 
8
 
C with a final
10-min extension at 72
 
8
 
C using Platinum Taq DNA polymerase
(GIBCO BRL) and the following primers: RAG1 sense
5
 
9
 
TGCAGACATCTCAACACTTTGG3
 
9
 
, antisense 5
 
9
 
ACATCT-
GCCTTCACATCGATCC3
 
9
 
; RAG2 sense exon 1A 5
 
9AGCAG-
CCCCTCTGGCCTTCAG39, exon 1B 59CCTTCAGACTGC-
GGTCTCCAG39, antisense 59TCCCTCGGCTGTACACCAC-
ATTAATG39; TdT sense 59GACACCACCAGATGGGCCAG-
CCAGAG39, antisense 59TGTTCTCTGCTACAATGTGGGT-
GAC39; Igb sense 59ATGGCCAGGCTGGCGTTGTCTC39,
antisense 59GAGGCGCTGTTCATGTAGCAGTG39. Since hu-
man RAG2 transcripts derive from two different alternative first
exons, RT-PCR was done with two 59 primers specific for exon
1A or exon 1B. Amplification of either of the two possible ma-
ture mRNAs results in the same size product. l-like– and
V-preB–specific primers have been previously described (40).
RT-PCR products were analyzed on 2% agarose gels and hybrid-
ized with cognate cDNAs amplified from the human pro-B cell line
JEA-2, which expresses all these transcripts (40). PhosphorImager
analysis was performed on samples amplified in the linear range.
Analysis of Mouse Cells. 4–6-wk-old  l5 targeted mice (41)
and C57Bl/6 controls were bred and maintained under specific
pathogen-free conditions. Mice were immunized with 50 mg of
NP-CGG in alum 10 d before analysis. Spleen cells from immu-
nized mice were stained with allophycocyanin-labeled anti-B220,
PE-labeled anti-k, PE-labeled anti–l-1 and -2, FITC-labeled
anti-GL7 (PharMingen, San Diego, CA), and biotin-labeled767 Meffre et al.
LM34 or SL156 anti-l5 antibodies (42) visualized with streptavi-
din-PerCP (Becton Dickinson). Four-color analysis was per-
formed on a FACScaliburÒ using Cellquest 3.1 (Becton Dickin-
son).
Immunohistochemistry. Acetone-fixed cryostat tonsil sections
(5  mm) were incubated with primary mouse mAbs against V-preB
(4G7) (Schiff, C., manuscript in preparation), followed by Alexa488-
conjugated goat anti–mouse Ig (Molecular Probes, Eugene, OR),
and/or anti-CD21 mAb (DAKO Corp.) followed by biotinylated
horse anti–mouse IgG (Vector Labs., Burlingame, CA) and Texas
red–conjugated streptavidin (Molecular Probes). Confocal laser
scanning microscopy was performed along the x and y axes with a
confocal laser scanning microscope (Leica Inc., Deerfield, IL)
equipped with an 320 oil objective.
Results and Discussion
To study the regulation of V(D)J recombination in pe-
ripheral B cells, we turned to human tonsils as a source of
large numbers of B cells that are readily fractionated into
naive FM B cells and GC B cells (38). To determine
whether human GC B cells actively undergo V(D)J recom-
bination we developed an assay for detecting blunt 59 phos-
phorylated human Igm and Igk RSS signal ends which are
specific intermediate products of the V(D)J recombination
reaction (references 39, 43; Fig. 1 a). JH6 and Jk5 were se-
lected because both are at the 39 ends of their respective J
regions and are least likely to be deleted during V(D)J re-
combination in the bone marrow. Using this assay PCR
products corresponding to the expected 59 phosphorylated
human JH6 and Jk5 signal ends were readily detected in hu-
man bone marrow, and were verified as specific by cloning
and sequencing (Fig. 1 b, and data not shown).
Having established the validity of the assay we examined
B cells from tonsils fractionated into IgD1CD382 naive
FM B cells, and IgD2CD381 GC cells. We found no RSS
signal breaks in the naive FM B cells (Fig. 1 b). In contrast,
GC B cells displayed Igk but no Igm RSS signal breaks.
The number of Igk RSS breaks in GC B cells could not be
determined precisely because the RSS break assay involves
a less than stoichiometric ligation reaction and two rounds
of amplification. Nevertheless, the amount DNA breaking
detected in GC samples was always 5–10-fold lower than
in bone marrow as determined by dilution. We conclude
that human GC B cells are actively undergoing V(D)J re-
combination at the Igk locus.
The absence of Igm RSS breaks in GC B cells may be
due to the 12/23 rule. DH segments are 12/23 compatible
with both VH and JH gene segments, but all DH segments
are deleted by any V to DJH joining event. VH to JH joining
is prohibited in the absence of DH segments by 12/23 in-
compatible RSSs (1). All mature B cells carry at least one
productive VDJH on one allele and in addition many B cells
have a nonproductive VDJH on the second allele (44).
Thus, there is a relative dearth of potential 12/23 compati-
ble targets for recombination at the heavy chain locus.
Consistent with this idea, heavy chain RSS breaks can be
found in activated B cells when DH segments are artificially
preserved by allelic exclusion in mice that carry targeted
VH genes (35). VH gene recombination using internal cryp-
tic heptamers as signals for recombination has been docu-
mented but would not be detected by our assay (45, 46).
Immunohistochemistry revealed that mouse RAG1 pro-
tein expression is most prominent in the GC light zone,
suggesting that recombination is activated in centrocytes
(33). To determine whether expression of other recombinase
components is restricted to a specific subset of mature B
cells, we separated human tonsil B lymphocytes into five frac-
tions by cell sorting: (a) FM cells, IgD1CD382; (b) mixed
FM cells and memory B cells, CD382CD772; (c) total GC
B cells, IgD2CD381; (d) GC centroblasts CD381CD771;
and (e) GC centrocytes, CD381CD772 (38). Centroblasts
are rapidly dividing early GC cells that initiate somatic mu-
tation, whereas switch recombination occurs primarily in
the centrocyte fraction that is derived from the centroblasts
(38, 47). RAG1, RAG2, TdT, l-like, and V-preB were
not expressed in resting FM B cells or in mixtures of FM B
cells and post-GC memory B cells (Fig. 2). In contrast, all
of these mRNAs were found in the GC fraction and
RAG1, RAG2, and TdT were specifically enriched in cen-
trocytes (Fig. 2). Although the PCR assay we used is only
semiquantitative, it is in the linear range and shows that the
levels of RAG1, RAG2, TdT, l-like, and V-preB mRNAs
in centrocytes are comparable to the levels of these mRNAs
found in unfractionated adult bone marrow samples as
Figure 1. Ligation-mediated (LM)-PCR
assay for detecting signal breaks in human
GC B cells. (a) Scheme for LM-PCR
strategy to detect RSS DNA breaks
within the human Ig k light chain locus.
A primary VkJk1 rearrangement is repre-
sented at the k locus, and after V(D)J
recombinase activation, downstream Jk
segments may be chosen for a secondary
rearrangement; Jk5 is depicted. Blunt signal ends at the nonamer–heptamer
sequences (triangles) are ligated to BW linkers. Linker-ligated DNA mole-
cules are then amplified by PCR using two sets of specific primers (see
Materials and Methods). (b) Jk signal breaks in human GC B cells.
LM-PCR for JH6 (top) and Jk5 (middle) signal breaks in human mononu-
clear bone marrow (BM) cells, naive CD382IgD1 FM tonsil B cells, and
CD381IgD2 GC B cells (left) and in centroblasts CD381CD771 and
centrocytes CD381CD772 ( right). PCR products were visualized with
locus-specific probes. PCR from a region overlapping the germline Jk5
segment was used as a control for DNA loading (bottom).768 Secondary V(D)J Recombination in Human Tonsil B Cells
measured by phosphorimaging. Low levels of RAG1 were
also found in centroblasts (20% of the levels in centrocytes
by phosphorimaging), but RAG2 was not detected in these
cells (Fig. 2). In accordance with the RAG mRNA expres-
sion data, Igk RSS breaks were found in centrocytes and
not in centroblasts (Fig. 1 b). Thus, receptor revision by
secondary V(D)J recombination is found in B cells that
have already passed through the centroblast stage where so-
matic mutation is initiated (38).
In developing B cells in the bone marrow, l-like and
V-preB proteins associate with each other as CLs that
combine with nascent heavy chains to form the pre-B cell
receptor (42, 48). The number of human bone marrow
cells that express surface CL is very small (1–3% of B cells;
references 40, 48, 49). Nevertheless, in both mouse and
human, B cell development is inefficient in the absence of
the CL (41, 50), presumably due to loss of B cells that ex-
press a heavy chain but no light chain. CL may play a sim-
ilar role in the GC B cell. According to this hypothesis, CL
would combine with heavy chains to rescue GC B cells
that have lost conventional light chain expression (33, 34,
37). To characterize the GC B cells that reexpress CL, we
stained human tonsil lymphocytes with anti–V-preB anti-
bodies in conjunction with anti-CD38, anti-Igk, and anti-
Igl antibodies (Fig. 3 a). Surface V-preB expression was
found on 0.85–11% of CD381 GC B cells in six indepen-
dent samples (both ends of the spectrum are shown in Fig.
3 a), whereas CD382 cells did not express V-preB (Fig. 3
a). In all cases, GC cells that expressed V-preB co-expressed
either Igk or Igl (Fig. 3 a and data not shown). The low
number of CL-positive cells in most of the human GC
samples is reminiscent of the low levels of CL on the sur-
face of human bone marrow cells (40, 48, 49). In contrast
to the human, CL are readily detected on the surface of
mouse B cells in the bone marrow (42). To confirm our
findings in human cells, we examined mouse spleen B cells
for l5 expression using two different anti-l5 antibodies
(reference 42; Fig. 3 b). In immunized mice, 15–20% of
B2201GL71 B cells expressed cell surface l5 (five consecu-
tive experiments), and, as in humans, these cells coex-
pressed either k or l light chains (Fig. 3 b). The relative ab-
sence of variability in CL expression on mouse peripheral
B cells as compared with human may be due to controlled
immunizations and the use of inbred mouse strains. Con-
trol B2201GL72 non-GC B cells did not express surface
CLs and neither did B2201GL71 B cells from l5 targeted
mice (Fig. 3 b). Furthermore, CLs are coexpressed with
RAGs in B2201GL71 B cells as determined by cell sorting
and RT-PCR analysis (data not shown). We conclude that
CLs are coexpressed with conventional light chains in
GL71 mature spleen B cells in mice and human, and that
loss of conventional light chains is not a prerequisite for ac-
tivation of CL expression in these cells.
GC B cells may not be the only peripheral B cells that
are CD381IgD2 (38). To directly confirm that CLs are ex-
pressed in GC B cells, we stained human tonsil tissue sec-
tions with anti-CD21 and anti–V-preB antibodies. Consis-
tent with the cell fractionation experiments, CL expression
was found in GCs (Fig. 4). In addition, occasional CL-pos-
itive B cells were found in the mantle and T cell zones.
These occasional CL-positive cells represent CD381IgD2
non-GC B cells because isolated CD382IgD1 FM B cells are
Figure 2. RAG, TdT, l-like, and V-preB gene expression in human
tonsil B cell subsets. RNA from FACSÒ-sorted CD382IgD1 FM B lym-
phocytes, CD382CD772 FM and memory B cells, CD381CD771 GC
centroblasts, CD381CD772 GC centrocytes, CD381IgD2 total GC B
cells, and mononuclear bone marrow (BM) cells was analyzed by semi-
quantitative RT-PCR and visualized with labeled oligonucleotide
probes. Igb RT-PCR was used as a B cell–specific mRNA loading con-
trol. PCR assays were designed to distinguish between genomic DNA
and mRNA using primers on different exons. PhosphorImager analysis
showed that there is a fivefold difference in the amount of RAG1 mRNA
amplified between centroblasts and centrocytes.
Figure 3. CL cell surface expression on GC B cells. (a) Flow cytomet-
ric analysis were performed on human tonsil B cells using anti-CD38,
anti–V-preB, anti-Igk, or anti-Igl. Two different patient samples are
shown. (b) Flow cytometric analysis of immunized wild-type and l5-tar-
geted (l52/2) mouse spleen cells using anti-B220, anti-GL7, anti-k, and
anti-l, and either LM34 or SL156 anti-l5 antibodies (42).769 Meffre et al.
always CL negative as measured by immunofluorescence
(data not shown). CL expressing non-GC CD381IgD2 B
cells may be recent bone marrow immigrants that are
CD381IgM1IgD2. We conclude that CLs are expressed in
human GC B cells but are also expressed in other tonsillar
B cells.
To define the requirements for RAG induction in pe-
ripheral B cells, we cocultured purified IgD1CD382 FM
and IgD2CD381 GC B cells with fibroblasts that express
CD40L and ILs (51). After 3 d of culture with CD40L,
resting FM B cells were induced to express high levels of
TdT mRNA, but did not express RAG1, RAG2, l-like,
or V-preB (Fig. 5 a). IgD2CD381 B cells differ from FM B
cells in that they express RAG1, RAG2, l-like, and
V-preB, and all of these mRNAs are maintained in cocul-
tures of GC B cells and CD40L-expressing fibroblasts (Figs.
2 and 5, a and b). Consistent with the results obtained with
FM cells, only TdT mRNA expression is upregulated in
the GC B cells in culture (Fig. 5 a). Addition of IL-2, IL-4,
or IL-10 was not sufficient for RAG induction in the rest-
ing FM B cells, and did not alter the levels of RAGs or
TdT expressed by GC B cells (Fig. 5 a). These results are in
contrast to experiments with mouse spleen B cells that ap-
peared to be induced to express RAGs in response to
CD40L plus IL-4 or LPS plus IL-4 (35, 36). We conclude
that reinduction of TdT in mature human B cells is medi-
ated through CD40, and that distinct pathways are required
to activate RAG expression.
Immature autoreactive IgM1IgD- bone marrow B cells
can be induced to reexpress RAGs when their receptors are
cross-linked by self-antigens (15, 52). Reexpression of
RAGs in these self-reactive B cells has been shown to delete
the auto-reactive receptors, and this process is referred to as
receptor editing (16–18). To determine whether RAG ex-
pression in peripheral B cells could also be modulated by
receptor cross-linking, we added anti-k and anti-l (anti-
k1l) antibodies to cultured IgD1CD382 and IgD2CD381
B cells (Fig. 5, a and b). In contrast to the activation of RAG
expression in bone marrow B cells, addition of anti-B cell
receptor (BCR) antibodies to cultured peripheral B cells in-
hibited the expression of RAG1, RAG2, and TdT (Fig. 5,
a and b). Anti-k1l antibodies also downregulated CD40L-
induced TdT expression in FM cells (Fig. 5 a). To further
Figure 4. CL expression in human tonsil B cells. Immunohistochemical staining of human tonsil sections was performed using anti–V-preB (left), anti-
CD21 (middle), or both (right). GCs, FM, and the T cell zones (T zone) are indicated.
Figure 5. Regulated expression of RAG, TdT, l-like, and V-preB
genes. (a) Human tonsil CD382IgD1 FM or CD381IgD2 GC B cells
were sorted (d0) and cultured on CD40L-transfected fibroblasts with or
without anti-k1l (a Ig) at 10 mg/ml, or IL-2, IL-4, or IL-10 for 3 d
(d3). Gene expression was analyzed by RT-PCR as described above. (b)
CD381IgD2 GC B cells were cultured with CD40L alone or with
CD40L and an irrelevant IgG control (Control Ig), or with intact anti-k (Ig
a–k) or anti-l (Ig a–l) or both (Ig a–k 1 a–l) or with Fab92 anti-k or
anti-l (Fab92 a–k 1 a–l). Antibody concentrations are indicated in mi-
crograms per milliliter. (c) GC cells reanalyzed by flow cytometry using
anti-CD38 and anti–V-preB mAbs after 3 d of culture with CD40L and
the indicated antibodies. GC B cells cultured with Ig a–k 1 a–l or
Fab92 a–k 1 a–l antibodies contained 1.5–2-fold more B cells than
those with cultured with control antibody, and the percentage of dead
cells was 40–50% in all of cultures as determined by trypan blue exclusion.770 Secondary V(D)J Recombination in Human Tonsil B Cells
characterize the suppressive effect of anti-BCR antibodies
on RAG expression, we performed dose–response experi-
ments with both intact anti-k1l antibodies and Fab92
fragments as well as control nonspecific antibody prepara-
tions (Fig. 5 b). mRNA levels were measured by semi-
quantitative RT-PCR and phosphorimaging. RAG1 and
RAG2 downregulation was observed with 10 mg/ml of in-
tact anti-k1l and as little as 2 mg/ml of Fab92 fragments of
anti-k1l antibody but was difficult to detect with 10 mg/ml
of intact anti-k or anti-l alone (RAG1 expression was de-
creased by a factor of 6–8 after treatment with 10 mg/ml of
intact anti-k1l antibody, and up to 203 after treatment
with 10 mg/ml of Fab92 fragments of anti-k1l; Fig. 5 b).
Direct measurements of cell viability showed that addition
of either intact or Fab92 fragments of anti-k1l antibodies
to the cultures did not result in increased cell death (see
legend to Fig. 5). More importantly, FACSÒ analysis
showed that the number cells undergoing “neoteny” (33)
did not change after anti-BCR cross-linking as determined
by anti–V-preB staining and confirmed by RT-PCR anal-
ysis of V-preB mRNA levels (Fig. 5, a–c). Thus, the effects
of anti-BCR antibodies on RAG expression cannot be ex-
plained by preferential killing of the specific subset of GC B
cells that are undergoing receptor revision (36). We con-
clude that the effect of receptor cross-linking on recombi-
nation-associated gene expression in peripheral B cells is
the opposite of the effect of cross-linking the same receptor
on immature IgM1IgD2 bone marrow B cells (15).
What is the function of receptor revision in the periph-
ery? Our experiments indicate that new antigen receptor
assembly does not require light chain inactivation and is not
likely to be a mechanism for removing autoreactive receptors
(Figs. 3 and 5). On the contrary, activation of recombina-
tion in cells that fail to bind antigen suggests that secondary
recombination may participate in repertoire diversification
by improving very low affinity receptors (35, 36). Expres-
sion of TdT lends further support to the notion that new
receptor diversification by gene recombination occurs in
mature B cells in the periphery since the only known func-
tion for TdT is to increase the diversity in the repertoire by
adding N nucleotides to V(D)J junctions (21, 22).
The idea that specific antibodies might be induced dur-
ing an immune response is difficult to accept because it is
directly contradictory to current interpretations of the
clonal selection theory (53, 54). Nevertheless, receptor as-
sembly in GC B cells is already a well established mecha-
nism for antibody diversification in avian immune systems
(55). In the chicken, Ig gene conversion is a prominent fea-
ture of the GC reaction, resulting in groups of interrelated
clones of B cells (55). In mice and humans, Ig recombina-
tion in GC B cells may be limited to the light chain genes.
Since much of the antibody-binding pocket is shaped by
the heavy chain, changing just the light chain could result
in a group of related B cells with antibodies that have a
spectrum of antigen binding affinities. Our findings are
consistent with the idea that secondary recombination is
terminated when antigen receptors are cross-linked and
suggest a mechanism for positive selection of B cells that
produce high affinity receptors by receptor revision in the
periphery.
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